Streptavidin conjugated anti-cat primary antibodies are detection reagents used in assays that require strong, highly specific signal generation from feline targets. They are part of biotin-based detection systems, where the antibody recognizes a cat antigen and the streptavidin component enables sensitive visualization through a linked reporter. This format is especially useful in veterinary research, immunohistochemistry, fluorescence imaging, and other protein detection workflows.

Principle of Streptavidin-Based Detection

The key feature of this system is the strong interaction between streptavidin and biotin. In practice, the anti-cat primary antibody is typically biotinylated, and streptavidin is then used as the detection partner, often carrying a fluorophore, enzyme, or other signal-generating label. This approach provides excellent sensitivity and can improve signal amplification, especially when the target antigen is present at low levels.

Antibody Specificity and Target Recognition

Anti-cat primary antibodies are designed to bind feline-specific proteins, including immune markers, structural proteins, and disease-associated antigens. Their specificity depends on the antigen used for immunization and on the validation performed during development. When paired with streptavidin-based detection, these antibodies can be applied in workflows that require both accuracy and flexibility.

Applications in Feline Research

These antibodies are widely used in immunohistochemistry, immunofluorescence, ELISA, and flow cytometry. They are valuable for studying feline immune responses, tissue organization, infectious disease markers, and biomolecular expression patterns. In diagnostic and translational research, they help improve detection of proteins that may be difficult to visualize with standard direct labeling methods.